Info@ThinkPinkRocks.com

Phase II study hints at oestriol effect in multiple sclerosis

Oestriol, given in combination with glatiramer acetate, may reduce the risk of relapse in women with relapsing–remitting multiple sclerosis, suggest findings from a phase II trial.

View post:
Phase II study hints at oestriol effect in multiple sclerosis

Share

Leave a Reply